After 30 years of listing, employees have something to say.
Release time:
2023-05-11
Fu Senqiang (Purchasing Department of Pharmaceutical Company):
I have been working in Peak for nearly 30 years, spent many unforgettable times and left many beautiful memories. At that time, I graduated from Wuxi Radio Industry School and was assigned to work in a cable factory under Jianfeng Group. I stepped into the society from the school. The change of identity made me feel very uncomfortable. Leaders at all levels also gave us new employees who had just entered the society. With the greatest patience and encouragement, we spared no effort to teach us how to behave and do things in order to integrate into the big family of the enterprise more quickly.
At that time, it happened to be the preparation and trial production stage of the cable company. During this period, it was inevitable to encounter various difficulties and emergencies. Every time I turned danger into safety, I fully appreciated the great wisdom and personality of the leader. charm. In daily work, the employees are sincere unity, regardless of personal gains and losses, fully reflects the strength of the team. Together, we have witnessed the development of an enterprise from scratch, from small to large, from strong to refined. I have grown together with the enterprise in this competitive, more inclusive and friendly atmosphere.
In 2009 , I was transferred to a pharmaceutical company. Under the environment of continuous impact and adjustment in the pharmaceutical industry, the pharmaceutical company can still occupy a place in the regional circulation industry. This is inseparable from the strong support of Jianfeng Group, which makes me feel the warmth of the Jianfeng family. At the same time, I am sincerely proud to be a Jianfeng person.
Accompanied by his good memories are the earth-shaking changes and many achievements of Jianfeng Group. With continuous transformation and development, it has effectively improved its overall strength and industry status. "Unity and struggle, realistic and innovative, determined to rise to the top, and always climb the peak" is the entrepreneurial spirit of the peak. As a member of the peak, I also fully feel the spiritual temperament of these 16 words. I believe this spirit will continue to inspire every peak. People climb the peak bravely, innovate continuously, and shoulder the mission bravely. The history of
30 years is not only a period of time, but also a precious wealth and an eternal memory in the hearts of every peak. In the future work, I will continue to uphold the spirit of the peak, and strive to contribute my own strength to the development and construction of the enterprise. Only when I think about the source can I go far. In the future development, the peak will not forget the original intention and continue to move forward. I believe With the joint efforts of all cadres and employees, the peak will have a better tomorrow!
Lu Chaofang (Peak Cable Technology Quality Department):
I joined Peak in 1997 and have been working in a cable company, from a small white cable to a professional and technical personnel of communication cables. During this growth process, I have made many mistakes, but Jianfeng is a very tolerant company, and every mistake I make has promoted my growth. The meaningful thing I can do now is to pass on these mistakes and sum up the experience to more people, so as to avoid detours and create more benefits. I think that there are many old employees who have worked in Jianfeng for decades or even for a lifetime like me, and it is because of this spirit of inheritance that the big family of Jianfeng will last forever.
This year marks the 30th anniversary of the group's listing and the 30th anniversary of the establishment of the cable company. It is precisely because of the listing of the group that there is a cable company and a world for our development. I hope that the peak can improve in digital transformation, intelligent manufacturing, reform and innovation, adapt to the trend of national development, create more benefits, and realize the great dream of a century of peak.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page